Want to see TSE:JUSH full AI Analyst Report?
JUSH Stock Chart & Stats
C$0.77
>-C$0.01(-1.16%)
At close: 4:00 PM EST
C$0.77
>-C$0.01(-1.16%)
Day’s Range― - ―
52-Week RangeC$0.49 - C$1.33
Previous CloseN/A
Volume6.90K
Average Volume (3M)104.97K
Market Cap
C$125.81M
Enterprise ValueC$508.99
Total Cash (Recent Filing)C$40.17M
Total Debt (Recent Filing)C$301.43M
Price to Earnings (P/E)―
Beta1.15
Next Earnings
Aug 06, 2026EPS Estimate
-0.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.36
Shares Outstanding199,696,600
10 Day Avg. Volume128,959
30 Day Avg. Volume104,975
Financial Highlights & Ratios
PEG Ratio-0.05
Price to Book (P/B)-1.07
Price to Sales (P/S)0.47
P/FCF Ratio285.60
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.21
Revenue Forecast (FY)C$270.52M
Bulls Say, Bears Say
Bulls Say
Vertical Integration & Wholesale ExpansionJushi's vertically integrated model (cultivation, manufacturing, retail) plus expanding wholesale reach creates durable margin capture and distribution scale. Adding 32 wholesale customers broadens channels, diversifies revenue across retail/wholesale, and supports brand penetration and SKU rollout over the medium term.
Improving Margins And Cash GenerationJushi shows sustained product-level profitability with higher gross margins and rising adjusted EBITDA while generating positive operating and free cash flow. That cash generation, coupled with margin expansion, strengthens the company's ability to fund operations, service debt, and reinvest versus prior years of negative cash flow.
Regulatory Tailwind From Federal ReschedulingFederal rescheduling removes a major structural tax disadvantage (Section 280E) for state-licensed medical operators and could materially lower future tax expense. With medical sales ~60% of revenue, this regulatory shift can sustainably improve after-tax margins and cash flow, pending implementation details.
Bears Say
Highly Leveraged Balance SheetNegative equity and large absolute debt leave capitalization fragile, constraining strategic flexibility. High leverage increases refinancing and covenant risk, limits ability to absorb shocks, and pressures credit-sensitive spending decisions, slowing durable investments and growth execution over the medium term.
Persistent Net LossesDespite revenue growth and solid gross margins, Jushi remains unprofitable at the net level. Continued GAAP losses erode retained capital, hinder equity rebuilding, and reduce flexibility to fund expansion internally, meaning profitability improvement must outpace financing and interest costs to be durable.
High Interest Burden & Refinancing RiskThe high-coupon term loan adds significant interest expense and leaves principal repayment risk when interest-only ends. Elevated interest costs reduce free cash flow available for growth or deleveraging, and refinancing risk at maturity remains a structural constraint on long-term financial resilience.
Jushi Holdings News
JUSH FAQ
What was Jushi Holdings’s price range in the past 12 months?
Jushi Holdings lowest stock price was C$0.49 and its highest was C$1.33 in the past 12 months.
What is Jushi Holdings’s market cap?
Jushi Holdings’s market cap is C$125.81M.
When is Jushi Holdings’s upcoming earnings report date?
Jushi Holdings’s upcoming earnings report date is Aug 06, 2026 which is in 17 days.
How were Jushi Holdings’s earnings last quarter?
Jushi Holdings released its earnings results on May 12, 2026. The company reported -C$0.14 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Jushi Holdings overvalued?
According to Wall Street analysts Jushi Holdings’s price is currently Overvalued.
Does Jushi Holdings pay dividends?
Jushi Holdings does not currently pay dividends.
What is Jushi Holdings’s EPS estimate?
Jushi Holdings’s EPS estimate is -0.07.
How many shares outstanding does Jushi Holdings have?
Jushi Holdings has 199,696,600 shares outstanding.
What happened to Jushi Holdings’s price movement after its last earnings report?
Jushi Holdings reported an EPS of -C$0.14 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.449%.
Which hedge fund is a major shareholder of Jushi Holdings?
Currently, no hedge funds are holding shares in TSE:JUSH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Jushi Holdings Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
40.27%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-2.70%
Trailing 12-Months
Company Description
Jushi Holdings
Jushi Holdings Inc., a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for the medical and adult-use markets in the United States. The company offers flowers, extracts, concentrates, edibles, pre-rolls, infused blunts, cannabis-infused gummies and chocolates, tinctures, capsules, softgels, and topical products, as well as vaporization devices and cartridges under the Hijinks, The Bank, The Lab, Tasteology, Uncommon Kind, Nira + Medicinals, and Sèche brands. It also engages in the sale of bulk raw materials to third parties. In addition, the company operates medical cannabis dispensaries under the Beyond Hello, Nature's Remedy, and NuLeaf brands. It markets its products to local dispensaries and large multi-state operators. Jushi Holdings Inc. was founded in 2018 and is headquartered in Boca Raton, Florida.